High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A

JAMA Neurology - United States
doi 10.1001/jamaneurol.2013.3178
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Erratum To: Respiratory Dysfunction in Charcot–Marie–Tooth Disease Type 1A

Journal of Neurology
Neurology
2015English

Hidden Hearing Loss in Patients With Charcot-Marie-Tooth Disease Type 1A

Scientific Reports
Multidisciplinary
2018English

Gait Pattern Classification in Children With Charcot–Marie–Tooth Disease Type 1A

Gait and Posture
Sports ScienceOrthopedicsSports MedicineRehabilitationBiophysics
2012English

Charcot-Marie-Tooth Disease Type 2R

2020English

Charcot-Marie-Tooth Disease Type 2B5

2020English

Charcot-Marie-Tooth Disease Type 4G

2020English

Antisense Oligonucleotides Offer Hope to Patients With Charcot-Marie-Tooth Disease Type 1A

Journal of Clinical Investigation
Medicine
2017English

Charcot–Marie–Tooth Disease

2012English

Autosomal Dominant Charcot-Marie-Tooth Disease Type 2A1

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy